CytoSorbents flags new CytoSorb clinical data presentations at EACTS, ESICM conferences
Bitget2026/09/30 11:04- CytoSorbents flagged new clinical data on its CytoSorb blood purification device for presentation at EACTS and ESICM in October 2026.
- Results have not yet been presented; the company outlined scheduled talks spanning cardiac surgery bleeding risk, post-surgery shock, ECMO-related inflammation, sepsis, ARDS.
- Presentations are set to highlight real-world registry experience, with outcomes framed around improved management of hyperinflammation and organ dysfunction in critical illness.
- The updates center on the COSMOS Registry, a key evidence-building program that could support broader clinical adoption across cardiac surgery and ICU use-cases.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi Turns More Bullish on Bitcoin and Strategy: Here Are the New Targets
South Korea's DRAM exports hit a record high of $33 billion in September.
QNT and NIGHT Continue to Defy Market Correction, BTC Settles After Wild Ride: Weekend Watch
Within just 40 days of its release, the split box office of iQIYI (IQ.US) "Soul Ferry" series of AI feature films exceeded 10 millions and continues to be popular.
From recouping initial investment in the first week to revenue sharing surpassing 10 million, AI unlocks the commercial value of classic IPs.
Crypto prices
More
